Antibody response after one and two jabs of the BNT162b2 vaccine in nursing home residents: The CONsort‐19 study

SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline

(2021) Shelly Bolotin et al.   JOURNAL OF INFECTIOUS DISEASES

Durability of SARS-CoV-2 IgG Antibody Among Residents in a Long-Term Care Community

(2021) Marcus D. Ruopp et al.   Journal of the American Medical Directors Association

Evolution of antibody immunity to SARS-CoV-2

(2021) Christian Gaebler et al.   NATURE

Atypical symptoms, SARS-CoV-2 test results and immunisation rates in 456 residents from eight nursing homes facing a COVID-19 outbreak

(2021) Hubert Blain et al.   AGE AND AGEING

Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020

(2021) Anna Jeffery-Smith et al.   Eurosurveillance

Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2

(2021) Saman Saadat et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

(2021) Zijun Wang et al.   NATURE

Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection

(2021) Federico Gobbi et al.   Viruses-Basel

Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors

(2021) J. Barrière et al.   ANNALS OF ONCOLOGY

Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia

(2021) Yair Herishanu et al.   BLOOD

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

(2021) Markus Hoffmann et al.   CELL

Humoral and cellular immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in nursing home residents

(2021) Jens T Van Praet et al.   CLINICAL INFECTIOUS DISEASES

Sera neutralizing activities against SARS-CoV-2 and multiple variants six month after hospitalization for COVID-19

(2021) Maureen Betton et al.   CLINICAL INFECTIOUS DISEASES

Spike Antibody Levels of Nursing Home Residents With or Without Prior COVID-19 3 Weeks After a Single BNT162b2 Vaccine Dose

(2021) Hubert Blain et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients

(2021) Liane Rabinowich et al.   JOURNAL OF HEPATOLOGY

Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study

(2021) Christian Holm Hansen et al.   LANCET

Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2

(2021) Joseph E. Ebinger et al.   NATURE MEDICINE

Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2

(2021) Yaniv Lustig et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients

(2021) Lorenzo Azzi et al.   VACCINE

Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)

(2021) Johannes Korth et al.   Viruses-Basel

COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program — Kentucky, March 2021

(2021) Alyson M. Cavanaugh et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination

(2021) Rishi R. Goel et al.   Science Immunology

Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis

(2021) Michael Jahn et al.   Vaccines

Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers

(2021) Andrea Padoan et al.   CLINICA CHIMICA ACTA

Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington

(2020) Temet M. McMichael et al.   NEW ENGLAND JOURNAL OF MEDICINE

Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients

(2020) E Tuaillon et al.   JOURNAL OF INFECTION

Efficacy of a Test-Retest Strategy in Residents and Health Care Personnel of a Nursing Home Facing a COVID-19 Outbreak

(2020) Hubert Blain et al.   Journal of the American Medical Directors Association

Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults

(2020) Mark J. Mulligan et al.   NATURE

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

(2020) F. Javier Ibarrondo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genomic evidence for reinfection with SARS-CoV-2: a case study

(2020) Richard L Tillett et al.   LANCET INFECTIOUS DISEASES

The Power of Antibody-Based Surveillance

(2020) Galit Alter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

(2020) Jeffrey Seow et al.   Nature Microbiology

Convalescent plasma anti–SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization

(2020) Eric Salazar et al.   JOURNAL OF CLINICAL INVESTIGATION

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

(2020) Sheila F. Lumley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preexisting Immunity, More Than Aging, Influences Influenza Vaccine Responses

(2015) Adrian J. Reber et al.   Open Forum Infectious Diseases

Antibody Response to Influenza A(H1N1)pdm09 Among Healthcare Personnel Receiving Trivalent Inactivated Vaccine: Effect of Prior Monovalent Inactivated Vaccine

(2013) M. Gaglani et al.   JOURNAL OF INFECTIOUS DISEASES